We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Vectura Group Plc | LSE:VEC | London | Ordinary Share | GB00BKM2MW97 | ORD 0.0271P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 164.80 | 164.80 | 165.00 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
04/9/2018 16:55 | UT 74.55p vol 147500 Looks like not short sellers - just panic sale imo or bad news coming neverending | a1ord53 | |
04/9/2018 16:43 | This is under a short attack - i am now wondering where they want it to hit. That trading pattern this afternoon is a classic hit on a relatively low volume stock. Expect some fear BS story to appear in the public arena in the next 24 hours. I remember well something similar happening in SKP just before a set of results on a scare story about sales of the Ellipta series not meeting forecasts. The share price dropped 15-20% over a few days. It was all, as i said at the time, BS and the share price recovered to the original level at the date of the results themselves, where the sales were in-line with previous guidance. The company cannot say anything unless it is price sensitive outside of current guidance, as they report next week. It leaves them open to short attack and conjecture. Today has also seen an unusual number of out of the ordinary size O trades, off direct market access trades (via broker/MMs). Suspicious! Any time you see a volume spike on no news on a share like VEC, you have to start wondering who is pulling the strings. Even if something is seriously amiss with guidance, then this type of action shows a horribly leaky ship. I suspect they are going for stops around the 70 mark. | polaris | |
04/9/2018 16:41 | We have a weak CEO whom I have long maintained (too many strategic mistakes) is not fit to be one-shorters sense this and so VEC, unlike many similarly positioned companies with competent management, is regularly subjected to this kind of attack. imo | cumnor | |
04/9/2018 16:41 | It would appear to be too little news too late. I hope you are right about some unexpected good news next week though. | jimboyce | |
04/9/2018 16:33 | This just got algo traded! I follow trading patterns and the share price has been very quiet over a couple of days and then, from around 2pm this afternoon the trades just took off, similar to the random trade/volume spikes from the previous out of the ordinary trading patterns from earlier in the year. I will be very interested to see what the UT trade size is at 1635. | polaris | |
04/9/2018 16:28 | We need VEC to do a Shire and Hikma. Where are Sosei and Gsk when we need them? | justiceforthemany | |
04/9/2018 16:28 | It was looking ugly at 140, at 120, at 100,90,80,70 This typical case of weak management and aggresive strong sellers , who dont trust management promises | a1ord53 | |
04/9/2018 16:27 | WTF has triggered this drop? Rigged markets. | justiceforthemany | |
04/9/2018 16:19 | That looks ugly.... | diesel | |
04/9/2018 15:29 | Snapped for 77.8 But very pessimistic about destiny of this company , was snapping from 150 p all way down to 70 and lost half - this company damned and SKP not for luck :( | a1ord53 | |
03/9/2018 11:47 | Just snapped up 10k of shares at 79.2. Been out for a while and there is always the previous floor circa 70 looming below but on balance I see this gradually re-establishing a mid-80s to 90 base imo ofc dyor. | rathean | |
03/9/2018 11:07 | I checked bid ask - on a bid 3600 shares on ask 15900 shares Vectura So sellers are back | a1ord53 | |
03/9/2018 09:40 | Q4 2018 in Europe and the US date was moved forward to Q4 2018 as well from Q1 2019. Not sure if the latter will also lead to a ruling. If we get another pop at 70p then i'm ready and waiting. | polaris | |
03/9/2018 09:05 | It looks like share price is under sale pressure again before results on 11 th of September.I will be not surprised that even if results will be good , share price will be going down and sellers will try squeeze longs. Unfortunately promised positive news flow not happening yet. When and where will be in Europe court HEARING/s against GSK ??? Anybody knows ??? | a1ord53 | |
02/9/2018 23:15 | ? Based on Closing Prices as of 15 March 2016 (being the last Business Day prior to the date of this announcement), the Enlarged Group would have had a pro-forma market capitalisation of £1,014.3 million and generated pro-forma combined revenues of £153.9 million and pro-forma combined EBITDA of £50.5 million based on the last reported full-year results for both companies. Quoted from the RNS at time of deal.Market cap today is £542m.So now nearly 50% drop in 2.5 years | jimboyce | |
02/9/2018 12:26 | Couldn’t agree more as I have stated we had been promised a string of positive mews flow as of yet VR647 which while welcome news hardly likely to move the share price short to medium term. Hbm do not appear to have sold down any further so maybe something of significance is in the pipeline hopefully that’s the case but it’s been a miserable time ever since the SKP merger that’s for sure. | best1467 | |
30/8/2018 08:53 | I do not think it is the amortisation charge that is keeping the share price low, I am sure investors are able to focus on EBITDA. In early March last year the share price was riding high even though a big loss had been reported due to a very much increased amortisation charge. I think the share price weakness is more related to the lack of any significant good news from the management since their change of strategy despite their bullish talk. | alexchry | |
30/8/2018 08:28 | Yes sadly it would appear that the amortisation charge is going to haunt the price of this share for some time to come. | jimboyce | |
29/8/2018 20:07 | Thanks for that but none of us really know what's going on normal for private investors. A | pooroldboy55 | |
29/8/2018 19:57 | Hi Andrew, Every time there is steady buying pressure then the momentum is slapped down by a persistent AT seller. This seems to correspond to the top of the falling channel. It must play out one of two ways: the seller loses as the price breaks out or the support level is broken to the downside. For me, it looks like it is being set-up for the H1 results. We know that there will be a headline loss due to the amortisation. The underlying business is fine. However, it might be enough to allow a gap down on the date of the results. I still do not see the long term plan for this seller/trader, unless it ends with a low ball offer after price engineering...and the predator is involved indirectly. Of course, this is illegal and so this can only be stated as IMO, as ever. regards, Paul | polaris | |
29/8/2018 19:50 | They do it because they can get away with it-they know we have a mundane, predictable CEO who has overseen the share price dropping by 60% on nothing but Advair delay-this should have impacted the share price to the extent of a 10-20p max but which strangely has not impacted Hikma at all. Had we even a half dynamic, average CEO with some status the hedgies and shorts would be wary lest they be surprised by an unpredictable deal or bit of news to hurt them. I have no idea why the current CEO is still here, given the company's disastrous share price performance over the past year. imo | cumnor | |
29/8/2018 19:47 | Hi Paul So how do you see thing's panning out because I haven't a clue. Cheers A | pooroldboy55 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions